Article
DLL3 Expression in a Genotyped Cohort of Sporadic Medullary Thyroid Carcinomas.
The American journal of surgical pathology - 1 Sept 2026
Riascos Maria Cristina, Najdawi Fedaa, Ahmadi Sara, Roberts Thomas J, Sehgal Kartik, Barletta Justine A
Abstract excerpt
Delta-like ligand 3 (DLL3) has been identified as a therapeutic target in high-grade neuroendocrine carcinomas, particularly small cell lung carcinoma. Data on DLL3 expression in medullary thyroid carcinoma (MTC) are limited; moreover, the relationship between DLL3 expression and MTC genotype has not been explored. We evaluated DLL3 expression (based on staining intensity and percentage of positive cells) in a...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.